The reports contents are as under – 1. Overview Typically, deal multiples are not available easily for analysis. Information is usually obtained through informal sources. To address these issues, we have calculated deal multiples based on company filings and our research. 2. Company wise details: - Player profile: Overview of the investee company, Geographic spread - Shareholding Pattern: Instrument, Break up of instrument, Percentage holding - Historical Financials: Profit & Loss Account, Balance Sheet, Key Ratios - Valuations: Investor, Instruments used, Amount Invested, Percentage stake acquired - Deal Multiples: EV/Sales, EV/EBITDA, P/E 3. List of companies in Part 1  ASG Eye Hospital  Forus  Axiss Dental  International Oncology  Centre for Sight  NationWide Primary Healthcare  DaVita NephroLife  NephroPlus  Diwan Chand  Xcyton 4. List of companies in Part 2  Beams Hospitals  Nova Medical  Enhance Aesthetic  Nueclear Healthcare  Eye – Q  R.G. Stone  Healthspring  Suburban Diagnostics  Mewar Hospital  The family doctor  My dentist

1. Reevolv Advisory Services
Private Limited
Healthcare Deal Multiples (Select Transactions) – Part II
For any queries or detailed information
Contact us on +91 – 22 – 6002 2001 / 2436 3161 or
email at research@reevolv.in
July 2014

2. Select Healthcare Transactions - Valuation Report
2
Table of Contents
Particulars Page Nos.
1. Executive Summary 3
2. Deal Multiples Summary 4
3. Player Profiles and Deal Multiples
3.1. Beams Hospitals 9
3.2. Enhance Aesthetic 15
3.3. Eye – Q 19
3.4. Healthspring 28
3.5. Mewar 36
3.6. My dentist 43
3.7. Nova Medical 50
3.8. Nueclear 64
3.9. R.G. Stone 69
3.10. Suburban Diagnostics 78
3.11. The family doctor 85
4. Annexure 91

3. Select Healthcare Transactions - Valuation Report
3
1. Executive Summary

4. Select Healthcare Transactions - Valuation Report
4
2. Deal Multiples Summary
No.
Healthcare
Companies
Name of investor/s Date
Amount
Invested
(Rs. Mn)
Year
Pre-
Money
(Rs. Mn)
EV
(Rs. Mn)
Revenue
(Rs. Mn)
EBITDA
(Rs. Mn)
PAT
(Rs. Mn)
EV /
Sales (x)
EV /
EBITDA
(x)
PE (x)
1
Beams
Hospital
XXX
XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX
XXX
2
Enhance
Aesthetic
XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
3 Eye - Q
XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX

5. Select Healthcare Transactions - Valuation Report
5
No.
Healthcare
Companies
Name of investor/s Date
Amount
Invested
(Rs. Mn)
Year
Pre-
Money
(Rs. Mn)
EV
(Rs. Mn)
Revenue
(Rs. Mn)
EBITDA
(Rs. Mn)
PAT
(Rs. Mn)
EV /
Sales (x)
EV /
EBITDA
(x)
PE (x)
3 Eye - Q XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX
4 Healthspring
XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX
XXX
XXX
5 Mewar XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX

6. Select Healthcare Transactions - Valuation Report
6
No.
Healthcare
Companies
Name of investor/s Date
Amount
Invested
(Rs. Mn)
Year
Pre-
Money
(Rs. Mn)
EV
(Rs. Mn)
Revenue
(Rs. Mn)
EBITDA
(Rs. Mn)
PAT
(Rs. Mn)
EV /
Sales (x)
EV /
EBITDA
(x)
PE (x)
6 My Dentist
XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX
XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX
7 Nova Medical XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX

7. Select Healthcare Transactions - Valuation Report
7
No.
Healthcare
Companies
Name of investor/s Date
Amount
Invested
(Rs. Mn)
Year
Pre-
Money
(Rs. Mn)
EV
(Rs. Mn)
Revenue
(Rs. Mn)
EBITDA
(Rs. Mn)
PAT
(Rs. Mn)
EV / Sales
(x)
EV /
EBITDA
(x)
PE (x)
7 Nova Medical
XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX XXX
8 Nueclear
XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX

8. Select Healthcare Transactions - Valuation Report
8
No.
Healthcare
Companies
Name of investor/s Date
Amount
Invested
(Rs. Mn)
Year
Pre-
Money
(Rs. Mn)
EV
(Rs. Mn)
Revenue
(Rs. Mn)
EBITDA
(Rs. Mn)
PAT
(Rs. Mn)
EV / Sales
(x)
EV /
EBITDA
(x)
PE (x)
9 R. G. Stone
XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
10
Suburban
Diagnostics
XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX
11
The Family
Doctor
XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX XXX XXX XXX XXX XXX XXX XXX XXX
XXX

9. Select Healthcare Transactions - Valuation Report
9
3. Player Profiles and Deal Multiples
3.1. xxx xxx
3.1.1. Overview
3.1.2. Location
Northern Region
No. of Centres
Main Cities
Eastern Region
No. of Centres
Main Cities
Western Region
No. of Centres
Main Cities
Southern Region
No. of Centres
Main Cities
Source : Company Website and Reevolv Research
Description
Company Name
Founder
Year of Inception/
Incorporation
Brand
Name of Investor/s
Total no. of centres
Treatment
Expansion Plans
Source: Company Website and Reevolv Research

10. Select Healthcare Transactions - Valuation Report
10
3.1.3. Shareholding Pattern as on xxxx
Equity Shares Preference Shares *
Number of
Shares
Paid up Percentage
Number of
Shares
Paid up Percentage
Director /
Relatives of Director
Foreign Holding
(FIIs/FCs/NRI/OCBs)
Venture Capital
Total
* 16% Compulsorily Convertible Cumulative Preference Shares
Face Value : Equity Share - Rs. xx/- per share, Preference Shares - Rs. xx/- per share
Source : Company Filings
Note :
• xxxx
3.1.4. Financials
Profit & Loss Account for the year ended 31st March (Rs. Mn)
FY2010 FY2011 FY2012 FY2013
Revenues from Operation
Other Income
Total Revenues
Cost of Materials Consumed
Rent, Rates and Taxes
Administrative and General Expenses
Employee Expenses
Selling and Distribution Expenses
Other Expenses
Total Expenditure
EBITDA
Depreciation
EBIT
Interest
PBT
PAT

11. Select Healthcare Transactions - Valuation Report
11
Balance Sheet as at 31st March (Rs. Mn)
FY2010 FY2011 FY2012 FY2013
Share Capital
Share Application Money
Reserves & Surplus
Shareholders’ Funds
Secured Loan
Unsecured Loan
Loan Funds
Deferred Tax Liability
Total Liabilities
Gross Block
Net Block
Capital work in progress
Investments
Inventories
Sundry Debtors
Other Current Assets
Total Current Assets & Advances
Current Liabilities
Provisions
Total Current Liabilities & Provisions
Net Working Capital excl. Cash & Bank
Cash & Bank
Net Working Capital incl. Cash & Bank
Total Assets
Source: Company Filings, Totals may not tally due to rounding off errors

12. Select Healthcare Transactions - Valuation Report
12
Key Ratios FY2010 FY2011 FY2012 FY2013
Profitability Ratios
EBITDA %
EBIT%
PBT %
PAT %
Return Ratios
ROCE %
ROE %
Financial Ratios
Total Debt / Net Worth
Secured Debt / Net Worth
Total Debt / EBITDA
Turnover Ratios
Working Capital Turnover Ratio
Net Fixed Assets Turnover Ratio
Inventory Days
Debtors Days
Source: Company Filings and Reevolv Research

13. Select Healthcare Transactions - Valuation Report
13
3.1.5. Valuation
Month & Year
Investor
Investor Company Name
Instrument 1
Instrument 2
Amount invested – Instrument 1 (Rs. Mn)
Amount invested – Instrument 2 (Rs. Mn)
Total Amount invested (Rs. Mn)
Instrument 1 – Equivalent stake (%)
Instrument 2 – Equivalent stake (%)
Total equivalent stake (%)
Primary stake %
Secondary stake %
Cumulative stake %
Source : Company Filings and Reevolv Research
Note
• xxxx
• xxxxxx

14. Select Healthcare Transactions - Valuation Report
14
XXXX
Month & Year
(Rs. Mn)
Pre-money
Debt
Cash and cash equivalents
Net Debt
EV
Post-money
Revenues
EBITDA
PAT
ROCE %
ROE %
EV/ Sales (x)
EV/EBITDA (x)
PE (x)
Source : Company Filings and Reevolv Research
Note :
• XXXXX
• XXXXXX
• XXXXXXX

15. Select Healthcare Transactions - Valuation Report
15
4. Annexure
4.1. Ratio
Key Ratios
Cost of Material Consumed %
Cost of Material Consumed
Total Revenues
X 100
Employee Expenses %
Employee Expenses
Total Revenues
X 100
Selling & Distribution Expenses %
Selling & Distribution Expenses
Total Revenues
X 100
Administrative Expenses %
Administrative Expenses
Total Revenues
X 100
EBITDA %
EBITDA
Total Revenues
X 100
EBIT %
EBIT
Total Revenues
X 100
PBT %
PBT
Total Revenues
X 100
PAT %
PAT
Total Revenues
X 100
ROCE %
EBIT
Capital Employed
X 100
ROE %
PAT
Net Worth
X 100
Capital Employed
Total of Asset / Liabilities
(Liabilities = Shareholders funds + Loan Funds + Deferred Tax + Minority Interest)
Working Capital Turnover Ratio
Total Revenues
Net Current Assets excl Cash Bank
Net Fixed Assets Turnover Ratio
Total Revenues
(Net Fixed Assets excl Capital Work in Progress)
Inventory Days
Inventory
(Cost of Material Consumed)
X 365
Debtors Days
Debtors
Total Revenues
X 365

16. Select Healthcare Transactions - Valuation Report
16
4.2. Abbreviations
Description
CCD Compulsory Convertible Debentures
CCPS Compulsory Convertible Preference Shares
CY Calendar Year
EBIT Earnings before interest and tax
EBITDA Earnings before interest, tax, depreciation and amortisation
EV Enterprise Value
FY Financial Year
NA Not Available
NM Not Meaningful
NR Not Relevant
P/E Price to earnings
PAT Profit after tax
PBT Profit before tax
ROCE Return on capital employed
ROE Return on equity

17. Select Healthcare Transactions - Valuation Report
17
About Reevolv
Reevolv is a boutique consulting and investment banking company offering a "One Stop Shop" in the
areas of business strategy, financial advisory and operations consulting to corporates and private equity
funds.
We service our clients in their constant re-evolution process through our in-depth industry research,
domain understanding, our timely and superior execution capabilities and strong network to provide
customized solutions to our clients.
With a host of implementation focused services spanning across functions, we ensure that our clients
reach the desired goals and objectives in most efficient manner. We achieve sustainability of our
initiatives by an all round involvement of the client resources. This approach of an integrated improvement
helps build a strong foundation for the forward leap of our clients. Reevolv understands and acts upon the
Strategic, Financial and Operational needs of the clients on a regular basis to ensure adaptability and
flexibility to suit the market and industry dynamics.
Founded in 2008, Reevolv is a team of CAs, MBAs and Engineers with functional and industry expertise
and diverse background of investment banking and management consulting.
Disclaimer
This report is published for information only. Reevolv Advisory Services Pvt. Ltd. or any of its affiliates,
group companies, directors, employees, agents or representatives shall not be liable for any loss or
damages whether direct or indirectthat may arise from or in connection with the use of the information in
this document. This document is the sole property of Reevolv Advisory Services Pvt. Ltd.and prior
permission is required for full or part reproduction.This information is strictly confidential and is being
furnished to you solely for your information. This information should not be reproduced or redistributed or
passed on directly or indirectly in any form to any other person or published, copied, in whole or in part,
for any purpose.
Contact Details
For any queries or detailed information contact us on
+91 22- 6002 2001 / 2436 3161 or email at research@reevolv.in
Address: No. B/002,Vision Court Staney Fernandes Wadi CHS Ltd., Plot no. 746, MTNL Exchange Lane,
Dadar (West), Mumbai 400 028
You can also email the research analyst at
Shilpa Bhattar
shilpa@reevolvindia.com, shilpa@reevolv.in